Company profile
Avantor, Inc.
NYSE: AVTR · Healthcare · Medical - Instruments & Supplies
PublicHQ Radnor, PACIK 0001722482Reports USD
#48 of 1,418 Healthcare companies by revenue36th-percentile growth
EA Score
68BFH 71DQ 70GM 52SS 75
v0.1 · 65/100 weight · provisional
↑ filing timeliness, market scale · ↓ listing tenure, 3-yr revenue growth
Methodology →Revenue TTM
$6.6B
Rev growth YoY (TTM)
-2.0%
Net income (FY)
-$530.2M
Employees
13,500
as of 2026-08-06
Market cap
$9.0B
as of 2026-08-06
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$6.6B$6.6B2025
Net income-$530.2M-$530.2M2025
Operating income-$246.2M-$246.2M2025
Total assets$11.8B$11.8B2025
Liabilities$6.2B$6.2B2025
Equity$5.6B$5.6B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY20
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Proprietary Materials And Consumables53%
Third Party Materials And Consumables47%
By geography
UNITED STATES50%
All Other Countries50%
The read
What is Avantor, Inc.’s revenue?
Avantor, Inc. booked $6.6B in FY2025 revenue, contracting 3.4% year over year — slower than 64% of Healthcare companies we track, at a -8.1% net margin.
Peers · Healthcare
Solventum Corporation65BZimmer Biomet Holdings, Inc.80B+Agilent Technologies, Inc.85AArdent Health Inc.61COrganon & Co.66BEdwards Lifesciences Corporation86AKey facts
CEOEmmanuel Ligner
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersRadnor, PA
ExchangeNYSE: AVTR
Employees13,500
IPO date2019-05-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.